TDCC Assay:
Revolutionizing Tumor Cell Cytotoxicity Assessment
Discover how the TDCC (Target-Dependent Cell Cytotoxicity) assay offers a cutting-edge approach to evaluating antibody efficacy by accurately measuring immune-mediated tumor cell killing. This white paper explores the assay’s methodology, applications, and advantages in immuno-oncology research and therapeutic development.
Explore the Full Whitepaper !
Powered by weForms